Lonza plans project in Genome ValleyIllustrative image – not actual.

Lonza AG, a Switzerland based pharmaceutical company, is likely to invest around Rs 250 crore through its Indian subsidiary in a phased manner in Genome Valley project on the outskirts of Hyderabad.

The project involves setting up a R&D facility in Phase I. the ground-breaking for the project is planned during Bio Asia-2011 summit to be held in February 2011.

Land for the project was allotted by Andhra Pradesh Industrial Infrastructure Corporation in June 2009.

← All latest storiesBack to top →